Side-by-side comparison of AI visibility scores, market position, and capabilities
Medical imaging annotation platform accelerating AI training data creation by 60%; $5.1M from Peak XV and YC serving hospitals and healthcare AI companies for FDA-cleared model development.
RedBrick AI is a healthcare AI platform specializing in medical imaging annotation — providing the configurable workflow system, annotation tools, and quality management features that hospitals, research institutions, and healthcare AI companies need to create high-quality training datasets for medical AI models. Founded in 2021 and backed by Peak XV Partners (formerly Sequoia Capital India) and Y Combinator with $5.1 million raised, RedBrick AI serves customers training AI models on CT scans, MRI, X-rays, and ultrasound images, accelerating annotation workflows by up to 60%.\n\nRedBrick AI's platform provides specialized annotation tools for 3D medical imaging (segmentation brushes for 3D volumes, DICOM viewer integration, measurement tools), configurable review workflows (managing the multi-step annotation, verification, and adjudication process required for medical-grade data quality), and active learning integration (prioritizing the most informative cases for human annotation to maximize model improvement per annotation hour). The platform handles the regulatory documentation requirements for medical AI development, including audit trails that support FDA submission.\n\nIn 2025, RedBrick AI competes in the medical AI training data and annotation market with Scale AI (general-purpose data annotation), Appen, CVAT (open-source), and specialized medical annotation platforms like MD.ai for medical image annotation tools. The healthcare AI market is growing rapidly as FDA-cleared AI diagnostic tools proliferate — each new radiology AI model requires thousands of annotated images for training, and the quality of annotations directly affects model safety. RedBrick AI's medical-specific tooling (3D annotation, DICOM handling, clinical workflow) provides depth that general annotation platforms lack. The 2025 strategy focuses on growing with hospital systems building internal AI capabilities, deepening regulatory compliance documentation, and expanding from imaging to other medical data modalities (pathology slides, clinical notes).
Cambridge/Colorado trapped-ion quantum computing (Honeywell majority; $625M+/$5B valuation Jun 2024); Helios Nov 2025 at 98 physical/48 logical qubits with 99.9975% fidelity serving Amgen/BMW/JPMorgan competing with IBM Quantum.
Quantinuum is a Cambridge, UK and Broomfield, Colorado-based integrated quantum computing company — majority owned by Honeywell (NASDAQ: HON) with $625+ million in total funding including a $300 million round led by JPMorgan Chase at a $5 billion valuation in June 2024 — operating the world's most accurate commercial quantum computers using trapped-ion technology combined with quantum software from Cambridge Quantum. In November 2025, Quantinuum launched Helios, its third-generation quantum computer featuring 98 physical qubits and 48 logical error-corrected qubits with 99.9975% single-qubit gate fidelity and 99.921% two-qubit gate fidelity — the highest-accuracy general-purpose commercial quantum computer commercially available. Serving enterprise customers including Amgen (drug discovery), BMW Group (materials simulation), JPMorgan Chase (financial optimization), and SoftBank Corp. (AI acceleration), Quantinuum was formed in November 2021 through the merger of Honeywell Quantum Solutions and Cambridge Quantum Computing. CEO Ilyas Khan.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.